HC Wainwright & Co. Reiterates Buy on Eton Pharmaceuticals, Maintains $70 Price Target

Benzinga · 1d ago
HC Wainwright & Co. analyst Swayampakula Ramakanth reiterates Eton Pharmaceuticals (NASDAQ:ETON) with a Buy and maintains $70 price target.